Robert Fulton

Medicine & Life Sciences

1. Genome 100%
2. Mutation 74%
3. Genes 54%
4. Acute Myeloid Leukemia 51%
5. Neoplasms 49%
6. Human Genome 33%
7. Whole Genome Sequencing 30%
8. Atlases 30%
9. Exome 28%
10. Precursor Cell Lymphoblastic Leukemia-Lymphoma 23%
11. Human Chromosomes 18%
12. Genomics 18%
13. Clone Cells 17%
14. High-Throughput Nucleotide Sequencing 16%
15. Chromosomes 16%
16. Myelodysplastic Syndromes 15%
17. Whole Exome Sequencing 15%
18. Myeloid Cells 13%
19. Chromosomes, Human, Pair 7 12%
20. Genetic Variation 12%
21. Breast Neoplasms 12%
22. GATA2 Deficiency 12%
23. Epigenomics 11%
24. RNA Sequence Analysis 11%
25. Population 10%
26. Nucleotides 10%
27. Retinitis Pigmentosa 10%
28. Proteins 10%
29. Clonal Evolution 10%
30. Genomic Structural Variation 9%
31. Yeast Artificial Chromosomes 9%
32. Microbiota 9%
33. Haplotypes 9%
34. Therapeutics 8%
35. Hematopoietic Stem Cells 8%
36. Neoplasm Genes 8%
37. Hematopoiesis 8%
38. Datasets 8%
39. Y Chromosome 8%
40. DNA 8%
41. Zea mays 8%
42. Single Nucleotide Polymorphism 8%
43. Sequence Tagged Sites 7%
44. Phenotype 7%
45. Sequence Analysis 7%
46. Glioma 7%
47. Recurrence 7%
48. DNA Methylation 7%
49. Genome-Wide Association Study 7%
50. Chromosomes, Human, X 7%